Bacteriophages in the human gut: Our fellow travelers throughout life and potential biomarkers of heath or disease

Virus Research

Volumn 240, Issue , 2017, Pages 47-55

  Bakhshinejad, Babak ^a   Ghiasvand, Saeedeh ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MALAYER UNIVERSITY   (Iran)

Author keywords

Biomarker; Gut; Phage; Phageome; Prophage

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

BACTERIOPHAGE; DISEASE MARKER; DYSBIOSIS; GENE EDITING; HEALTH; HORIZONTAL GENE TRANSFER; HUMAN; INTESTINE; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; REVIEW; ANIMAL; CLASSIFICATION; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; BACTERIOPHAGES; BIOMARKERS; GASTROINTESTINAL TRACT; HEALTH; HUMANS;

EID: 85026682770     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2017.07.013     Document Type: Review

References (86)

1. Allen, H.K., Looft, T., Bayles, D.O., Humphrey, S., Levine, U.Y., Alt, D., Stanton, T.B., Antibiotics in feed induce prophages in swine fecal microbiomes. MBio 2:6 (2011), e00211–e00260.
2. Andoh, A., Imaeda, H., Aomatsu, T., Inatomi, O., Bamba, S., Sasaki, M., Saito, Y., Tsujikawa, T., Fujiyama, Y., Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J. Gastroenterol. 46:4 (2011), 479–486.
3. Angly, F., Rodriguez-Brito, B., Bangor, D., McNairnie, P., Breitbart, M., Salamon, P., Felts, B., Nulton, J., Mahaffy, J., Rohwer, F., PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information. BMC Bioinf., 6(1), 2005, 41.
4. Barr, J.J., Youle, M., Rohwer, F., Innate and acquired bacteriophage-mediated immunity. Bacteriophage 3:3 (2013), 10771–10776.
5. Bedi, D., Musacchio, T., Fagbohun, O.A., Gillespie, J.W., Deinnocentes, P., Bird, R.C., Bookbinder, L., Torchilin, V.P., Petrenko, V.A., Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomed. Nanotechnol. Biol. Med. 7:3 (2011), 315–323.
6. Bedi, D., Gillespie, J.W., Petrenko, V.A. Jr, Ebner, A., Leitner, M., Hinterdorfer, P., Petrenko, V.A., Targeted delivery of siRNA into breast cancer cells via phage fusion proteins. Mol. Pharm. 10:2 (2013), 551–559.
7. Bondy-Denomy, J., Pawluk, A., Maxwell, K.L., Davidson, A.R., Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:7432 (2013), 429–432.
8. Breitbart, M., Haynes, M., Kelley, S., Angly, F., Edwards, R.A., Felts, B., Mahaffy, J.M., Mueller, J., Nulton, J., Rayhawk, S., Viral diversity and dynamics in an infant gut. Res. Microbiol. 159:5 (2008), 367–373.
9. Broaders, E., Gahan, C.G., Marchesi, J.R., Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes 4:4 (2013), 271–280.
10. Cadwell, K., Expanding the role of the virome: commensalism in the gut. J. Virol. 89:4 (2015), 1951–1953.
11. Cao, B., Yang, M., Mao, C., Phage as a genetically modifiable supramacromolecule in chemistry, materials and medicine. Acc. Chem. Res. 49:6 (2016), 1111–1120.
12. Carlton, R.M., Phage therapy: past history and future prospects. Archivum Immunologiae Et Therapiae Experimentalis-English Edition 47 (1999), 267–274.
13. Chibani-Chennoufi, S., Bruttin, A., Dillmann, M.-L., Brüssow, H., Phage-host interaction: an ecological perspective. J. Bacteriol. 186:12 (2004), 3677–3686.
14. Cho, J.-H., Kim, A.-R., Kim, S.-H., Lee, S.-J., Chung, H., Yoon, M.-Y., Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133. Acta Biomater. 47 (2017), 182–192.
15. Columpsi, P., Sacchi, P., Zuccaro, V., Cima, S., Sarda, C., Mariani, M., Gori, A., Bruno, R., Beyond the gut bacterial microbiota: the gut virome. J. Med. Virol. 88:9 (2016), 1467–1472.
16. Cui, J., Ren, H.J., Liu, R.D., Wang, L., Zhang, Z.F., Wang, Z.Q., Phage-displayed specific polypeptide antigens induce significant protective immunity against Trichinella spiralis infection in BALB/c mice. Vaccine 31:8 (2013), 1171–1177.
17. Dalmasso, M., Hill, C., Ross, R.P., Exploiting gut bacteriophages for human health. Trends Microbiol. 22:7 (2014), 399–405.
18. Duerkop, B.A., Hooper, L.V., Resident viruses and their interactions with the immune system. Nat. Immunol. 14:7 (2013), 654–659.
19. Frenkel, D., Dewachter, I., Van Leuven, F., Solomon, B., Reduction of β-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21:11 (2003), 1060–1065.
20. Furuse, K., Osawa, S., Kawashiro, J., Tanaka, R., Ozawa, A., Sawamura, S., Yanagawa, Y., Nagao, T., Watanabe, I., Bacteriophage distribution in human faeces: continuous survey of healthy subjects and patients with internal and leukaemic diseases. J. Gen. Virol. 64:9 (1983), 2039–2043.
21. Gandra, N., Abbineni, G., Qu, X., Huai, Y., Wang, L., Mao, C., Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy. Small 9:2 (2013), 215–221.
22. Giang, E., Dorner, M., Prentoe, J.C., Dreux, M., Evans, M.J., Bukh, J., Rice, C.M., Ploss, A., Burton, D.R., Law, M., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc. Natl. Acad. Sci. 109:16 (2012), 6205–6210.
23. Gupta, S., Allen-Vercoe, E., Petrof, E.O., Fecal microbiota transplantation: in perspective. Therapeut. Adv. Gastroenterol. 9:2 (2016), 229–239.
24. Hsiung, P.-L., Hardy, J., Friedland, S., Soetikno, R., Du, C.B., Wu, A.P., Sahbaie, P., Crawford, J.M., Lowe, A.W., Contag, C.H., Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat. Med. 14:4 (2008), 454–458.
25. Huddleston, J.R., Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infect. Drug Resist., 7, 2014, 167.
26. Huddleston, J.R., Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infect. Drug Resist. 7 (2014), 167–176.
27. Janardhanan, S.K., Narayan, S., Abbineni, G., Hayhurst, A., Mao, C., Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy. Mol. Cancer Ther. 9:9 (2010), 2524–2535.
28. Keen, E.C., A century of phage research: bacteriophages and the shaping of modern biology. Bioessays 37:1 (2015), 6–9.
29. Kelly, K.A., Waterman, P., Weissleder, R., In vivo imaging of molecularly targeted phage. Neoplasia 8:12 (2006), 1011–1018.
30. Larimer, B.M., Deutscher, S.L., Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer. Am. J. Nucl. Med. Mol. Imaging, 4(5), 2014, 435.
31. Leib-Mösch, C., Brack-Werner, R., Werner, T., Bachmann, M., Faff, O., Erfle, V., Hehlmann, R., Endogenous retroviral elements in human DNA. Cancer Res. 50:17 Supplement (1990), 5636s–5642s.
32. Lepage, P., Colombet, J., Marteau, P., Sime-Ngando, T., Doré, J., Leclerc, M., Dysbiosis in inflammatory bowel disease: a role for bacteriophages?. Gut 57:3 (2008), 424–425.
33. Licznerska, K., Nejman-Faleńczyk, B., Bloch, S., Dydecka, A., Topka, G., Gąsior, T., Węgrzyn, A., Węgrzyn, G., Oxidative stress in Shiga toxin production by enterohemorrhagic Escherichia coli. Oxid. Med. Cell. Longevity, 2016, 2015.
34. Liu, J., Glazko, G., Mushegian, A., Protein repertoire of double-stranded DNA bacteriophages. Virus Res. 117:1 (2006), 68–80.
35. Lysholm, F., Wetterbom, A., Lindau, C., Darban, H., Bjerkner, A., Fahlander, K., Lindberg, A.M., Persson, B., Allander, T., Andersson, B., Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS One, 7(2), 2012, e30875.
36. Malito, E., Faleri, A., Surdo, P.L., Veggi, D., Maruggi, G., Grassi, E., Cartocci, E., Bertoldi, I., Genovese, A., Santini, L., Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc. Natl. Acad. Sci. 110:9 (2013), 3304–3309.
37. Manrique, P., Bolduc, B., Walk, S.T., van der Oost, J., de Vos, W.M., Young, M.J., Healthy human gut phageome. Proc. Natl. Acad. Sci., 201601060, 2016.
38. Manrique, P., Dills, M., Young, M.J., The human gut phage community and its implications for health and disease. Viruses, 9(6), 2017, 141.
39. Melzer, H., Fortugno, P., Mansouri, E., Felici, F., Marinets, A., Wiedermann, G., Kollaritsch, H., Von Specht, B.U., Duchene, M., Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica. Parasite Immunol. 24:6 (2002), 321–328.
40. Mills, S., Shanahan, F., Stanton, C., Hill, C., Coffey, A., Ross, R.P., Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4:1 (2013), 4–16.
41. Min, J., Jung, H., Shin, H.-H., Cho, G., Cho, H., Kang, S., Implementation of P22 viral capsids as intravascular magnetic resonance T 1 contrast conjugates via site-selective attachment of Gd (III)-chelating agents. Biomacromolecules 14:7 (2013), 2332–2339.
42. Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S.A., Wu, G.D., Lewis, J.D., Bushman, F.D., The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21:10 (2011), 1616–1625.
43. Minot, S., Grunberg, S., Wu, G.D., Lewis, J.D., Bushman, F.D., Hypervariable loci in the human gut virome. Proc. Natl. Acad. Sci. 109:10 (2012), 3962–3966.
44. Modi, S.R., Lee, H.H., Spina, C.S., Collins, J.J., Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499:7457 (2013), 219–222.
45. Moelling, K., Broecker, F., Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases. Bacteriophage, 6(4), 2016, e1251380.
46. Mokili, J.L., Rohwer, F., Dutilh, B.E., Metagenomics and future perspectives in virus discovery. Curr. Opin. Virol. 2:1 (2012), 63–77.
47. Moran, N.A., Degnan, P.H., Santos, S.R., Dunbar, H.E., Ochman, H., The players in a mutualistic symbiosis: insects, bacteria, viruses, and virulence genes. Proc. Natl. Acad. Sci. U. S. A. 102:47 (2005), 16919–16926.
48. Ogilvie, L.A., Jones, B.V., The human gut virome: a multifaceted majority. Front. Microbiol., 6, 2014, 918.
49. Oliver, K.M., Degnan, P.H., Hunter, M.S., Moran, N.A., Bacteriophages encode factors required for protection in a symbiotic mutualism. Science 325:5943 (2009), 992–994.
50. Ott, S.J., Waetzig, G.H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J.A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152:4 (2017), 799–811.e7 (e797).
51. Pérez-Brocal, V., García-López, R., Vázquez-Castellanos, J.F., Nos, P., Beltrán, B., Latorre, A., Moya, A., Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach. Clin. Trans. Gastroenterol., 4(6), 2013, e36.
52. Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., Brown, P.O., Development of the human infant intestinal microbiota. PLoS Biol., 5(7), 2007, e177.
53. Paterson, S., Vogwill, T., Buckling, A., Benmayor, R., Spiers, A.J., Thomson, N.R., Quail, M., Smith, F., Walker, D., Libberton, B., Antagonistic coevolution accelerates molecular evolution. Nature 464:7286 (2010), 275–278.
54. Popgeorgiev, N., Temmam, S., Raoult, D., Desnues, C., Describing the silent human virome with an emphasis on giant viruses. Intervirology 56:6 (2013), 395–412.
55. Reyes, A., Haynes, M., Hanson, N., Angly, F.E., Heath, A.C., Rohwer, F., Gordon, J.I., Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466:7304 (2010), 334–338.
56. Reyes, A., Semenkovich, N.P., Whiteson, K., Rohwer, F., Gordon, J.I., Going viral: next-generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 10:9 (2012), 607–617.
57. Rodriguez-Valera, F., Martin-Cuadrado, A.-B., Rodriguez-Brito, B., Pašić, L., Thingstad, T.F., Rohwer, F., Mira, A., Explaining microbial population genomics through phage predation. Nat. Rev. Microbiol. 7:11 (2009), 828–836.
58. Ruthruff, B., Clinical review of Crohn's disease. J. Am. Ass. Nurse Pract. 19:8 (2007), 392–397.
59. Salmond, G.P., Fineran, P.C., A century of the phage: past, present and future. Nat. Rev. Microbiol. 13:12 (2015), 777–786.
60. Samson, J.E., Magadán, A.H., Sabri, M., Moineau, S., Revenge of the phages: defeating bacterial defences. Nat. Rev. Microbiol. 11:10 (2013), 675–687.
61. Sanger, F., Nucleotide Sequence of Bacteriophage (D X174 DNA). 1977.
62. Sharon, I., Morowitz, M.J., Thomas, B.C., Costello, E.K., Relman, D.A., Banfield, J.F., Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res. 23:1 (2013), 111–120.
63. Shterzer, N., Mizrahi, I., The animal gut as a melting pot for horizontal gene transfer 1. Can. J. Microbiol. 61:9 (2015), 603–605.
64. Smith, G.P., Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985), 1315–1318.
65. Solomon, B., Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment. J. Alzheimer's Dis. 15:2 (2008), 193–198.
66. Souza, G.R., Christianson, D.R., Staquicini, F.I., Ozawa, M.G., Snyder, E.Y., Sidman, R.L., Miller, J.H., Arap, W., Pasqualini, R., Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc. Natl. Acad. Sci. 103:5 (2006), 1215–1220.
67. Stern, A., Sorek, R., The phage-host arms race: shaping the evolution of microbes. Bioessays 33:1 (2011), 43–51.
68. Stern, A., Mick, E., Tirosh, I., Sagy, O., Sorek, R., CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Res. 22:10 (2012), 1985–1994.
69. Sunderland, K., Yang, M., Mao, C., Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine. 2016, Angewandte Chemie.
70. Suthiwangcharoen, N., Li, T., Li, K., Thompson, P., You, S., Wang, Q., M13 bacteriophage-polymer nanoassemblies as drug delivery vehicles. Nano Res. 4:5 (2011), 483–493.
71. Thingstad, T.F., Elements of a theory for the mechanisms controlling abundance, diversity, and biogeochemical role of lytic bacterial viruses in aquatic systems. Limnol. Oceanogr. 45:6 (2000), 1320–1328.
72. Twort, F.W., An investigation on the nature of ultra-microscopic viruses. Lancet 186:4814 (1915), 1241–1243.
73. Ursell, L.K., Metcalf, J.L., Parfrey, L.W., Knight, R., Defining the human microbiome. Nutr. Rev. 70:suppl_1 (2012), S38–S44.
74. Vinay, M., Franche, N., Grégori, G., Fantino, J.-R., Pouillot, F., Ansaldi, M., Phage-based fluorescent biosensor prototypes to specifically detect enteric bacteria such as E. coli and Salmonella enterica typhimurium. PLoS One, 10(7), 2015, e0131466.
75. Virgin, H.W., Wherry, E.J., Ahmed, R., Redefining chronic viral infection. Cell 138:1 (2009), 30–50.
76. Virgin, H.W., The virome in mammalian physiology and disease. Cell 157:1 (2014), 142–150.
77. Wagner, J., Maksimovic, J., Farries, G., Sim, W.H., Bishop, R.F., Cameron, D.J., Catto-Smith, A.G., Kirkwood, C.D., Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm. Bowel Dis. 19:8 (2013), 1598–1608.
78. Wang, X., Kim, Y., Ma, Q., Hong, S.H., Pokusaeva, K., Sturino, J.M., Wood, T.K., Cryptic prophages help bacteria cope with adverse environments. Nat. Commun., 1, 2010, 147.
79. Wang, J., Wang, L., Yang, M., Zhu, Y., Tomsia, A., Mao, C., Untangling the effects of peptide sequences and nanotopographies in a biomimetic niche for directed differentiation of iPSCs by assemblies of genetically engineered viral nanofibers. Nano Lett. 14:12 (2014), 6850–6856.
80. Wang, J., Yang, M., Zhu, Y., Wang, L., Tomsia, A.P., Mao, C., Phage nanofibers induce vascularized osteogenesis in 3D printed bone scaffolds. Adv. Mater. 26:29 (2014), 4961–4966.
81. Wang, Y., Ju, Z., Cao, B., Gao, X., Zhu, Y., Qiu, P., Xu, H., Pan, P., Bao, H., Wang, L., Ultrasensitive rapid detection of human serum antibody biomarkers by biomarker-capturing viral nanofibers. ACS Nano 9:4 (2015), 4475–4483.
82. Winter, C., Bouvier, T., Weinbauer, M.G., Thingstad, T.F., Trade-offs between competition and defense specialists among unicellular planktonic organisms: the killing the winner hypothesis revisited. Microbiol. Mol. Biol. Rev. 74:1 (2010), 42–57.
83. Yacoby, I., Shamis, M., Bar, H., Shabat, D., Benhar, I., Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob. Agents Chemother. 50:6 (2006), 2087–2097.
84. Yeh, C.-Y., Hsiao, J.-K., Wang, Y.-P., Lan, C.-H., Wu, H.-C., Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer. Biomaterials 99 (2016), 1–15.
85. Zhou, X., Cao, P., Zhu, Y., Lu, W., Gu, N., Mao, C., Phage-mediated counting by the naked eye of miRNA molecules at attomolar concentrations in a Petri dish. Nat. Mater. 14:10 (2015), 1058–1064.
86. d'Herelle, F., Sur un microbe invisible antagoniste des bacilles dysent'riques. CR Acad. Sci. Paris 165 (1917), 373–375.